BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ECETOC Work on Risk Assessment Wins Prestigious Prize


3/7/2013 11:02:29 AM

Brussels, 6 March 2013 – ECETOC’s work on the identification and evaluation of endocrine disrupting chemicals has been recognised by the American Society of Toxicology (SOT) whose Risk Assessment Specialty Section (RASS) awarded it ‘Best Published Paper Advancing the Science of Risk Assessment’.

The award-winning ECETOC paper, ‘Risk assessment of endocrine active chemicals: Identifying chemicals of regulatory concern’, provides a science-based set of criteria to be used in the evaluation and regulation of substances with endocrine disrupting properties.

This paper was published by an ECETOC task force established in 2008 to provide scientific input on the evaluation criteria for endocrine disrupters. In chemicals legislation today, including REACH, the fundamental criteria to define endocrine disrupting properties are not defined. The ECETOC task force recommends the use of key scientific criteria including chemicals’ potency, specificity and severity of effects, relevance of mode of action of toxicity and negligible exposure etc.

The paper’s lead author Dr Remi Bars said, “This award reinforces the importance of considering all available scientific information including hazard assessment and exposure consideration to properly regulate chemicals with endocrine disrupting properties.”

Dr Alan Poole, Secretary General of ECETOC said, “We are grateful that the Society Of Toxicology has recognised the significance of the ECETOC task force’s contribution to the risk management of hormone active agents. I congratulate the task force on their outstanding work.”

The paper was publ ished in the Regulatory Toxicology and Pharmacology Journal in 2012 and can be accessed here. !It "#$%&' #()*!+*!,+-%$,-!paper published in 2011 in the same journal.

*ECETOC is Europe’s leading industry association for developing and promoting top quality science in human and environmental risk assessment of chemicals.

Media Contact:

Kathryn Sheridan

ks@sustainabilityconsult.com

Europe: +32 496 116 198/North America: (202) 470 3239



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES